Avantor Investor Conference Presentation Deck

Serving attractive end markets >$75B TAM growing mid-single digits BIOPHARMA $34B TAM +HSD growth Enabling life-altering, breakthrough treatments for patients O 50% of revenue Navantor™ HEALTHCARE $10B TAM +MSD growth Helping protect the health and well-being of people across the globe LSD low-single digit MSD mid-single digit HSD high-single digit TAM total addressable market 10% of revenue EDUCATION & GOVERNMENT $16B TAM +LSD growth Helping move science forward with precise, reliable research products 15% of revenue ORGANIC GROWTH $ ADVANCED TECHNOLOGIES $16B TAM +MSD growth C 25% of revenue Providing ultra-high-purity solutions essential for the world's most demanding environments 39th Annual J.P. Morgan Healthcare Conference 11

View entire presentation